The contribution of clinical pharmacology to antimalarial drug discovery and development

British Journal of Clinical Pharmacology

Volumn 55, Issue 5, 2003, Pages 464-468

  Winstanley, Peter ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CHLORPROGUANIL; CHLORPROGUANIL PLUS DAPSONE; CLINDAMYCIN; DAPSONE; FANSIDAR; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; SULFADOXINE; TETRACYCLINE;

ANEMIA; CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; HUMAN; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; PARASITEMIA; PREGNANCY; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

AFRICA; ANTIMALARIALS; DRUG COSTS; DRUG DESIGN; FEMALE; HUMANS; MALARIA; MALARIA, FALCIPARUM; PHARMACOLOGY, CLINICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SAFETY; TREATMENT OUTCOME;

EID: 0038662521     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01845.x     Document Type: Conference Paper

References (10)

1. Snow RW, Craig MH, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of World Health Organisation 1999; 77: 624-640.
2. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131 (2S-2): 604S-614S; discussion 614S-615S.
3. Sachs J. Helping the world's poorest. The Economist August 14, 1999; 17-20.
4. Trape JF, Pison G, Preziosi MP, et al. Impact of chloroquine resistance on malaria mortality. Comples Rendus l'Academie Des Sci Series 3, Sci la Vie 1998; 321: 689-697.
5. Olliaro P, Mussano P. Amodiaquine for treating malaria. Cochrane Database Syst Rev 2000; CD000016.
6. Mutabingwa T, Nzila A, Mberu E, et al. Drug resistant falciparum malaria in Tanzania: chlorproguanil-dapsone is effective treatment for infections resistant to pyrimethamine-sulfadoxine. Lancet 2003; in press.
7. van Hensbroek MB, Morris-Jones S, Meisner S, et al. Iron but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 672-676.
8. Meshnick SR. Artemisinin antimalarials: mechanisms of action and resistance. Med Trop (Mars) 1998; 58 (3 Suppl): 13-17.
9. http://www.foundation.novartis.com/malaria_riamet_china.htm.
10. Nzila A, Nduati E, Mberu E, et al. Molecular evidence of greater selective pressure for drug resistance exerted by the long acting antifolate pyrimethamine/sulfadoxine compared with the shorter acting chlorproguanil-dapsone on Kenyan Plasmodium falciparum. J Inf Dis 2000; 181: 2023-2028.